IRVINE, Calif., July 19, 2005 (PRIMEZONE) -- "Entertainer Michael J. Fox's pressure on Congress to lift President Bush's limitations on stem cell research could reopen opportunities for stem cell companies," stated SmallCap Sentinel analyst, D.R. Clark. "Fox's popular appeal and the bipartisan support of Senators Tom Harkin (D-Iowa) and Arlen Spector (R-Pennsylvania) could be a potent combination in repealing Bush's prohibitive rules on stem cell research."
"Other vocal proponents of stem cell research including Nancy Reagan, Mary Tyler Moore and Christopher Reeve's widow add strength to the group looking to overturn Bush's restrictions," added Clark.
An informational report titled "Looking at the Political Impact on Stem Cell Research" has been made available free of charge via financial courier StockUpTicks.com at www.SmallCapSentinel.com
New Life Scientific (OTCBB:NWLF), which endeavors to blend Eastern European research & development with Western management, joins Stemcells Inc. (Nasdaq:STEM), Aastrom Biosciences Inc. (Nasdaq:ASTM), and Geron Corp. (Nasdaq:GERN) as companies potentially affected by any governmental restrictions regarding stem cell research.
Individuals may also register to receive free future reports at: http://stockupticks.com/register.html
Statements made herein contain forward-looking statements and are subject to significant risks and uncertainties that will affect the results. SmallCap Sentinel and StockUpTicks.com are properties of Market Pathways Financial Relations Inc. (MP). MP provides no assurance as to the subject company's plans or ability to effect any proposed actions and cannot project its capabilities, intent, resources, or experience.
All information contained herein is based upon sources believed to be reliable but no representation is made as to its accuracy or completeness. This report is neither a solicitation to buy nor an offer to sell securities but is rather a paid advertisement provided for information purposes only and should not be used as the basis for any investment decision. MP is not an investment advisor and this report is not investment advice. MP has been paid thirty-six hundred dollars for preparation and distribution of this report and other advertising services by Emerging Markets Consulting LLC. This constitutes a conflict of interest as to MP's ability to remain objective in its communication regarding the subject companies.